Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A. Copland, Keith L. Knutson, Carole Soussain, Han W. Tun

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model'. Together they form a unique fingerprint.